AUG 19, 2020 12:24 PM PDT

Link between microbiome and cancer treatment outcomes

New research published in the journal European Urology reports that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes in immunotherapy regimens. The research adds to already-established evidence supporting the critical importance of the gut microbiome in myriad aspects of the body.

"Previous studies have suggested a relationship between the gut microbiome and response to immunotherapy in solid tumors, including metastatic kidney cancer," said lead author Nicholas Salgia, B.Sc., a clinical research assistant at City of Hope. "The results from our study build on earlier findings and reaffirm that the diversity and composition of patients' microbiomes are associated with clinical responses to anti-cancer therapies."

Salgia and other City of Hope physicians worked alongside TGen scientists (Translational Genomics Research Institute) to analyze data from 31 people with metastatic kidney cancer. Participants provided stool samples throughout different time points in the treatment (baseline, four weeks into therapy and 12 weeks into therapy) so that the researchers could identify changes in the microbiome over time.

The team found that greater diversity in the gut microbiome was associated with improved treatment outcomes. "We also reported the changes over time in the gut microbiome that occur during the course of therapy -- the cumulative findings from our report open the door to therapies directed at the microbiome," said senior author Sumanta Pal, M.D. who is co-director of the Kidney Cancer Program at City of Hope.

"The patients with the highest benefit from cancer treatment were those with more microbial diversity, but also those with a higher abundance of a specific bacterium known as Akkermansia muciniphila," said senior author Sarah Highlander, Ph.D., a research professor in TGen's Pathogen and Microbiome Division. "This organism has been associated with benefit in other immunotherapy studies."

Photo: Pixabay

The researchers say there is also potential to improve treatment outcomes by manipulating the gut microbiome during the therapy. For example, taking a probiotic supplement and eating a high-fiber diet high in fructooligosaccharides could help patients undergoing treatment.

The team hopes that these findings will pave the way towards developing personalized treatment plans for metastatic kidney cancer patients. In order to continue with their investigations, they plan to expand their study to follow a larger size group over more time.

Sources: European Urology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 17, 2020
Cancer
Are Cancer Exosomes a Good Source of Biomarkers?
AUG 17, 2020
Are Cancer Exosomes a Good Source of Biomarkers?
One of cancer’s most aggravating qualities is its ability to control the microenvironment around it. This control ...
AUG 21, 2020
Cancer
Firefighters risk greater carcinogenic exposure than previously thought
AUG 21, 2020
Firefighters risk greater carcinogenic exposure than previously thought
New research published in the journal Environment International suggests that firefighters may be more exposed to c ...
OCT 06, 2020
Cannabis Sciences
Cannabis Use May Reduce Cancer Risk by 10%
OCT 06, 2020
Cannabis Use May Reduce Cancer Risk by 10%
A recent meta-analysis of 34 studies found that cannabis use may decrease one’s risk of developing certain kinds o ...
OCT 11, 2020
Cancer
Targeting neoantigens to improve immunotherapies
OCT 11, 2020
Targeting neoantigens to improve immunotherapies
Neoantigens are extremely small biomarkers forming from cancer mutations that demonstrate the presence of cancerous cell ...
OCT 21, 2020
Cancer
Can Excess Fructose Cause Liver Cancer?
OCT 21, 2020
Can Excess Fructose Cause Liver Cancer?
Hepatocellular carcinoma, aka liver cancer, is an ever-increasing issue in the western world. While the lion’s sha ...
OCT 23, 2020
Cancer
#BCSM helps physicians understand patients' needs outside the clinical setting
OCT 23, 2020
#BCSM helps physicians understand patients' needs outside the clinical setting
A new study from UCLA published in the Journal of Patient-Centered Research and Review suggests that social media can be ...
Loading Comments...